WHO ICTRP trial

Effect of Bacillus clausii in the management of acute diarrhoea in children

CTRI/2024/02/062669 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2024/02/062669
Public title Effect of Bacillus clausii in the management of acute diarrhoea in children
Scientific title Comparative study on clinical efficacy of Bacillus Clausii ( Bifilac Clausi ) in the management of acute diarrhoea in children as an add on therapy with standard therapy- A randomized control study - NIL
Primary sponsor Tablets India Limited
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 4
Countries India
Conditions Health Condition 1: A084- Viral intestinal infection, unspecified
Interventions Intervention1: Bifilac Clausi: Bacillus Clausii 2 billion CFU Intervention2: Bifilac Clausi + ORS + Zinc: Bacillus clausii 2 billion CFU for 5 days BD ORS Zinc sulphate 20 mg for 14 days Control Intervention1: ORS + Zinc: ORS + Oral Zinc…
Registration date Feb 15, 2024
Target size 90
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations